Allogene Therapeutics, Inc. (ALLO) Debt Components
- 2018-12-31: Convertible Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD (m); Long-term Debt, Fair ValueUSD $141.40M.
- 2018-10-31: Convertible Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD (m); Long-term Debt, Fair ValueUSD $141.40M.
- 2018-09-30: Convertible Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD $120.20M; Long-term Debt, Fair ValueUSD $120.20M.
- 2018-09-30: Convertible Notes Payable, CurrentUSD $139.62M; Debt Instrument, Face AmountUSD (m); Long-term Debt, Fair ValueUSD (m).
Allogene Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Debt Instrument, Face Amount USD | Long-term Debt, Fair Value USD |
|---|---|---|---|
| 2018-12-31 | (m) | (m) | $141.40M |
| 2018-10-31 | (m) | (m) | $141.40M |
| 2018-09-30 | (m) | $120.20M | $120.20M |
| 2018-09-30 | $139.62M | (m) | (m) |
| 2018-09-05 | (m) | (m) | $120.20K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |